Back HIV Populations Women & HIV

Women & HIV

ICAAC 2011: Cobicistat Matches Ritonavir as Booster, Studies Clarify Effects on Kidney Function

The experimental pharmacoenhancing agent cobicistat continues to work as well as ritonavir for boosting other antiretroviral drugs, according to findings published in the September 24, 2011, issue of AIDS.

In addition, 2 studies presented this week at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) shed further light on cobicistat's impact on the kidneys, indicating that it reduces estimated but not actual glomerular filtration rate (GFR) by altering activity in the proximal renal tubules.

Read more:

ICAAC 2011: Raltegravir is Effective and Well-tolerated in Diverse Populations with HIV

The HIV integrase inhibitor raltegravir (Isentress) works well for both men and women and people of diverse racial/ethnic groups, according to data from the REALMRK trial presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) this week in Chicago.alt

Read more:

IAS 2011: Hormonal Contraceptive Use Increases Women’s Risk of Acquiring and Transmitting HIV

A two-year, seven-country study has concluded that women using hormonal contraceptives, particularly injectable forms, are at a greater risk both of acquiring HIV themselves and of passing it on to a male sexual partner.alt

Read more:

CDC Fact Sheets on HIV among Women and Transgender People

The U.S. Centers for Disease Control and Prevention (CDC) recently announced the availability of an updated fact sheet on HIV among Women, as well as a new fact sheet on HIV among Transgender People.alt

Read more:

IAS 2011: HIV Prevention -- A Women's Revolution [VIDEO]

The 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) held last week in Rome heralded remarkable data showing that early HIV treatment and pre-exposure prophylaxis (PrEP) can dramatically reduce the risk of HIV transmission.

But biomedical prevention methods will only work if people have access to them, and many women worldwide do not have access due to lack of economic resources or the right of self-determination.alt

Read more: